Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass Grafting

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT01159639

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01159639
Other papers using this trial's data
  • Impact of aspirin resistance on outcomes among patients following coronary artery bypass grafting: exploratory analysis from randomized controlled trial (NCT01159639) Journal of thrombosis and thrombolysis, 2015-05 DOI, PubMed 25095738
  • Impact of dual antiplatelet therapy on outcomes among aspirin-resistant patients following coronary artery bypass grafting The American journal of cardiology, 2014-05-15 DOI, PubMed 24666617
  • Postoperative Atrial Fibrillation Is Associated With High On-Aspirin Platelet Reactivity The Annals of thoracic surgery, 2015-11 DOI, PubMed 26215778

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Croatia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01159639. Randomized; no masking; primary purpose prevention. Start 2010-06 (registry gives no type); primary completion 2013-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass Grafting
Condition
Aspirin Resistance
Intervention (Drug)
Clopidogrel
Lead sponsor
University of Zagreb (class: other)

Record details

Record id
cardio:ct-nct01159639
Content hash
c983e0669d1148b83da6b166de03dbdf23c57b63e78e513292c8068cf900872b